FundComb

Investment & M&A transaction comps

Consumer Health Investment & M&A Transaction Comps

Explore investment and M&A transactions tagged consumer health. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.

Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.

Explore 46 transactions ↓ Browse all comp sectors →
Reviewed transactions
46
With value data
29
With revenue multiples
24
Transaction years
2006–2026

Sortable transaction comps

Consumer Health transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

18 / 21

Acquisition EV, USD

USD 62B

Investment EV, USD

USD 36B

Median EV / revenue

4.4x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

21 shown of 46 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.

Select for comparison
2020-12-01 Church & Dwight 513 4.8x -
Consumer Health
Zicam
Control
 2020-12-01 Church & Dwight 530 5.9x 14.7x
Consumer Health
Smarty Pants
Control (100%)
 2020-11-25 Unilever Undisclosed 4.0x -
SupplementsConsumer Health
Natrol LLC
Control (100%)
 2020-10-26 New Mountain Capital 550 3.5x -
SupplementsConsumer Health
2020-09-22 Chr. Hansen Holding A/S 367 6.2x -
SupplementsConsumer Health
2020-09-15 Groupe Lactalis S.A. 3,300 1.8x 12.4x
Consumer Health
2020-06-25 Novozymes 90 6.0x -
SupplementsConsumer Health
2018-12-19 GlaxoSmithKline (GSK-Pfizer consumer joint venture) Undisclosed - -
SupplementsConsumer Health
2018-12-03 Hindustan Unilever and Unilever 5,999 9.6x -
SupplementsConsumer Health
2018-04-19 The Procter & Gamble Company 3,700 3.7x 17.2x
Consumer Health
2018-03-27 GlaxoSmithKline 35,616 3.6x 20.1x
Consumer Health
2018-03-27 GlaxoSmithKline plc Undisclosed - -
Consumer Health
Life-Space Group
Control (100%)
 2018-01-31 BY-HEALTH Co., Ltd. 543 - -
SupplementsConsumer Health
2017-12-05 Nestlé 2,300 3.3x 19.0x
SupplementsConsumer Health
2016-12-15 Church & Dwight Co., Inc. 130 5.4x -
Personal CareConsumer Health
2016-06-27 Sanofi 7,300 4.4x 16.1x
Consumer Health
Nutraceutix assets
Control (100%)
 2016-06-06 Probi AB 105 3.1x 13.1x
SupplementsConsumer Health
2014-05-06 Bayer 14,200 6.5x 21.0x
Consumer Health
2010-07-21 Reckitt Benckiser 3,878 3.5x 20.5x
Consumer Health
2007-12-11 Reckitt Benckiser Group plc 2,300 6.4x 30.4x
Consumer HealthPharma
2006-06-25 Johnson & Johnson 16,600 - -
Consumer Health

Explore related tags

Continue to the full transaction history for each tag.

Consumer 34Supplements 19Vitamins 12CPG 7Pain Relief 5Pharma 5Cough & Cold 4Healthcare 4Women's Health 4Probiotics 3

Explore buyers & investors

Church & Dwight 3GlaxoSmithKline (GSK-Pfizer consumer joint venture) 3Haleon plc 3Reckitt Benckiser Group plc 3Unilever 3Nestle 2Pharmavite 2Alliance Pharma plc 1

Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.

Values may be estimated, rumored, incomplete or derived from public information. Transaction comps are informational and should not be relied on as financial, investment or valuation advice.